ArticleCureus2026
Intravenous Bolus Phenylephrine and Intravenous Bolus Norepinephrine for Treatment of Maternal Hypotension in Spinal Anesthesia During Cesarean Section: A Prospective, Randomized, Comparative Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background A fall in maternal blood pressure is frequently encountered following spinal anesthesia for cesarean delivery. This hemodynamic disturbance primarily results from reduced venous return, leading to a decline in cardiac output and/or systemic vascular resistance. The primary objective of this study was to estimate the efficacy and safety of norepinephrine and phenylephrine for the treatment of maternal post-spinal hypotension during cesarean section. The secondary objective was to compare the hemodynamics and neonatal APGAR scores between the two vasopressors. Methodology This prospective, randomized trial included 72 parturients scheduled for cesarean section. Before the administration of spinal anesthesia, participants were allocated using computer-generated randomization into the following two groups: norepinephrine (Group A) and phenylephrine (Group B). Group A received an intravenous bolus of norepinephrine 4 μg (4 μg/mL), while Group B was administered an intravenous bolus of phenylephrine 50 μg (50 μg/mL). Both study drugs were prepared by dilution with normal saline. Results The mean systolic blood pressure showed a decline in both groups for up to the initial two minutes and a gradual elevation later. A significantly greater decline in heart rate was noted in the phenylephrine group (Group B) compared with the norepinephrine group (Group A) at multiple time points during observation. In addition, patients receiving phenylephrine required fewer rescue bolus doses than those receiving norepinephrine, with the difference reaching high statistical significance (p < 0.0001). Both groups showed no statistically significant difference (p = 0.3938) in neonatal outcome, assessed by the one-minute APGAR score. The majority of neonates in both groups had APGAR scores in the moderate range (4-6), accounting for 88.89% in Group A and 94.44% in Group B. There was a statistically insignificant difference in APGAR score in both groups (p = 0.3139) at five minutes, with 100% and 97.22% of patients falling under the reassuring category of score 7-9 in Group A and Group B, respectively. Conclusions An intermittent bolus of norepinephrine is as effective as an intermittent bolus of phenylephrine for the treatment of maternal hypotension in spinal anesthesia during cesarean section. However, the incidence of heart rate reduction was much higher with phenylephrine than with norepinephrine. The number of bolus doses required was higher with norepinephrine than with phenylephrine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.